The Biopreservation market size is USD 4.7 Billion in 2026.
The Biopreservation market is projected to grow at a CAGR of 34% by 2033, reaching approximately USD 37.2 Billion.
The Biopreservation market growth drivers include rising prevalence of chronic diseases and obesity, increasing investments in regenerative medicine and biobanking, and growing demand for personalized medicine.
North America is the dominating region for the Biopreservation market.
Thermo Fisher Scientific Inc., Merck KGaA, Avantor, Inc., BioLife Solutions, Inc., and STEMCELL Technologies, Inc. are some leading industry players in the Biopreservation market.